Kezar Life Sciences Inc. (NASDAQ: KZR)
$0.66
+0.0052 ( +0.80% ) 193.1K
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.
Market Data
Open
$0.66
Previous close
$0.65
Volume
193.1K
Market cap
$48.03M
Day range
$0.65 - $0.67
52 week range
$0.54 - $2.55
SEC Fillings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 4 | Insider transactions | 1 | Jun 21, 2024 |
| 8-k | 8K-related | 11 | Jun 21, 2024 |
| 4 | Insider transactions | 1 | Jun 21, 2024 |
| 4 | Insider transactions | 1 | Jun 21, 2024 |
| 4 | Insider transactions | 1 | Jun 21, 2024 |
| 4 | Insider transactions | 1 | Jun 21, 2024 |
| 4 | Insider transactions | 1 | Jun 21, 2024 |
| 8-k | 8K-related | 11 | Jun 04, 2024 |
| 8-k | 8K-related | 12 | May 09, 2024 |
| 10-q | Quarterly Reports | 77 | May 09, 2024 |